| HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT RBC CAPITAL MARKETS HEALTHCARE CONFERENCE |
|
[webcast] ROCKVILLE, Maryland – March 1, 2010 -- Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the RBC Capital Markets 2010 Healthcare Conference will be webcast and may be accessed at www.hgsi.com. A member of Human Genome Sciences’ senior management team will present a corporate overview on Wednesday, March 3, 2010, at 11:00 AM Eastern time. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event. The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer. HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company’s web site at www.hgsi.com. # # #
Media Contact: |